WO2026093944 - MANUFACTURE OF CANCER CELLS IN A CLOSED AND STERILE SYSTEM
National phase entry is expected:
Publication Number
WO/2026/093944
Publication Date
07.05.2026
International Application No.
PCT/IB2025/061025
International Filing Date
29.10.2025
Title **
[English]
MANUFACTURE OF CANCER CELLS IN A CLOSED AND STERILE SYSTEM
[French]
FABRICATION DE CELLULES CANCÉREUSES DANS UN SYSTÈME FERMÉ ET STÉRILE
Applicants **
THOME KREUTZ, Fernando
Inventors
THOME KREUTZ, Fernando
Priority Data
63/713,639
30.10.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
APO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Natural Person
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2793 | |
| EPO | Filing, Examination, Granting | 14919 | |
| Japan | Filing, Examination, Granting | 2915 | |
| South Korea | Filing, Examination, Granting | 3681 | |
| USA | Filing, Examination, Granting | 8540 |
Total:
32,848
Contact Us
Abstract[English]
A method for generating modified cancer cells is provided. The method comprises obtaining a sample comprising unmodified cancer cells; separating unmodified cancer cells from other cell populations in the sample; and modifying the unmodified cancer cells in a cultivation chamber to produce modified cancer cells. The method is performed in a closed and sterile cell culture system. In typical aspects, the method is automated. A system for performing the method on a device and uses of the modified cancer cells are also provided.[French]
L'invention concerne une méthode de production de cellules cancéreuses modifiées. La méthode consiste à obtenir un échantillon comprenant des cellules cancéreuses non modifiées ; à séparer des cellules cancéreuses non modifiées d'autres populations de cellules dans l'échantillon ; et à modifier les cellules cancéreuses non modifiées dans une chambre de culture pour produire des cellules cancéreuses modifiées. La méthode est effectuée dans un système de culture cellulaire fermé et stérile. Dans des aspects typiques, la méthode est automatisée. L'invention concerne également un système de réalisation de la méthode sur un dispositif et des utilisations des cellules cancéreuses modifiées.